PT921787E - Regime de administracao de inibidores de atpase de h',k' - Google Patents

Regime de administracao de inibidores de atpase de h',k'

Info

Publication number
PT921787E
PT921787E PT97930933T PT97930933T PT921787E PT 921787 E PT921787 E PT 921787E PT 97930933 T PT97930933 T PT 97930933T PT 97930933 T PT97930933 T PT 97930933T PT 921787 E PT921787 E PT 921787E
Authority
PT
Portugal
Prior art keywords
atpase inhibitor
administration scheme
inhibitor administration
atpase
extended
Prior art date
Application number
PT97930933T
Other languages
English (en)
Inventor
George Sachs
Christer Cederberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT921787E publication Critical patent/PT921787E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
PT97930933T 1996-06-20 1997-06-18 Regime de administracao de inibidores de atpase de h',k' PT921787E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (sv) 1996-06-20 1996-06-20 Administration of pharmaceuticals

Publications (1)

Publication Number Publication Date
PT921787E true PT921787E (pt) 2004-03-31

Family

ID=20403092

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97930933T PT921787E (pt) 1996-06-20 1997-06-18 Regime de administracao de inibidores de atpase de h',k'

Country Status (28)

Country Link
US (4) US20010008900A1 (pt)
EP (1) EP0921787B1 (pt)
JP (1) JP2000512993A (pt)
CN (1) CN1178648C (pt)
AT (1) ATE252885T1 (pt)
AU (1) AU726859B2 (pt)
BR (1) BR9709838A (pt)
CA (1) CA2257405A1 (pt)
CZ (1) CZ298213B6 (pt)
DE (1) DE69725860T2 (pt)
DK (1) DK0921787T3 (pt)
EE (1) EE04606B1 (pt)
ES (1) ES2208921T3 (pt)
HK (1) HK1018590A1 (pt)
HU (1) HUP9901794A3 (pt)
IL (2) IL127542A0 (pt)
IS (1) IS2216B (pt)
NO (1) NO323295B1 (pt)
NZ (1) NZ332990A (pt)
PL (1) PL189716B1 (pt)
PT (1) PT921787E (pt)
RS (1) RS49590B (pt)
RU (1) RU2203662C2 (pt)
SE (1) SE9602442D0 (pt)
SK (1) SK284204B6 (pt)
TR (1) TR199802647T2 (pt)
UA (1) UA64715C2 (pt)
WO (1) WO1997048380A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
WO1999055157A1 (en) * 1998-04-30 1999-11-04 Sepracor Inc. R-rabeprazole compositions and methods
JP2002512263A (ja) * 1998-04-30 2002-04-23 セプラコール， インク． Ｓ−レイブプラゾール組成物及び方法
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
CA2338311C (en) 1998-08-10 2007-01-23 Michael E. Garst Prodrugs of the pyridyl methyl sulfinyl benzimidazoles
AU772726B2 (en) 1998-08-12 2004-05-06 Takeda Gmbh Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
AU6713194A (en) * 1993-04-27 1994-11-21 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
BR9506018A (pt) * 1994-07-08 1997-09-02 Astra Ab Forma farmacêutica oral de múltipla dosagem unitária em tablete processos para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem e para o tratamento das doenças inflamatórias gastrointestinais em mamiferos e no homem e embalagem de ampola de pressão transversal
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole

Also Published As

Publication number Publication date
HUP9901794A3 (en) 2002-11-28
EP0921787B1 (en) 2003-10-29
JP2000512993A (ja) 2000-10-03
SK284204B6 (sk) 2004-10-05
US20010008900A1 (en) 2001-07-19
UA64715C2 (en) 2004-03-15
US20070276007A1 (en) 2007-11-29
RU2203662C2 (ru) 2003-05-10
ES2208921T3 (es) 2004-06-16
SE9602442D0 (sv) 1996-06-20
EE04606B1 (et) 2006-04-17
NO985964L (no) 1999-02-22
CN1178648C (zh) 2004-12-08
US20090036494A1 (en) 2009-02-05
US20050113418A1 (en) 2005-05-26
DK0921787T3 (da) 2004-02-23
AU726859B2 (en) 2000-11-23
IL127542A (en) 2006-08-01
DE69725860D1 (de) 2003-12-04
WO1997048380A1 (en) 1997-12-24
PL330910A1 (en) 1999-06-07
IL127542A0 (en) 1999-10-28
EP0921787A1 (en) 1999-06-16
CA2257405A1 (en) 1997-12-24
IS2216B (is) 2007-03-15
HK1018590A1 (en) 1999-12-30
NZ332990A (en) 2000-07-28
AU3469097A (en) 1998-01-07
RS49590B (sr) 2007-06-04
IS4923A (is) 1998-12-15
SK165598A3 (en) 1999-08-06
YU56698A (sh) 2004-12-31
HUP9901794A2 (hu) 2000-04-28
NO985964D0 (no) 1998-12-18
DE69725860T2 (de) 2004-09-09
BR9709838A (pt) 1999-08-10
CN1222074A (zh) 1999-07-07
TR199802647T2 (xx) 1999-03-22
CZ298213B6 (cs) 2007-07-25
CZ420398A3 (cs) 2000-02-16
EE9800435A (et) 1999-06-15
NO323295B1 (no) 2007-03-05
PL189716B1 (pl) 2005-09-30
ATE252885T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
SE9504661D0 (sv) New compounds
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
AP9701041A0 (en) Pyridylpyrrole compounds.
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
AU3475097A (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
AP9801202A0 (en) Atropisomers of 3-heteroaryl-4(3H)-quinazolinones.
LV11728A (lv) Farmaceitiska kompozicija
SE9504662D0 (sv) New compounds
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
AP9801235A0 (en) Erythromycin derivatives.
DE69430074T2 (de) Analgetische 4-arylisoindolen
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase